Apoptosis modulators in the therapy of neurodegenerative diseases.
about
Identification of novel functional inhibitors of acid sphingomyelinaseOxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventionsConserved actin cysteine residues are oxidative stress sensors that can regulate cell death in yeast.The neuroprotective functions of transforming growth factor beta proteinsThe tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis inductionThe antiapoptotic activity of melatonin in neurodegenerative diseases.Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeysCo-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.Milk thistle seed extract protects rat C6 astroglial cells from acute cocaine toxicity.Neuroprotection for Parkinson's disease: a new approach for a new millennium.Dopaminergic substitution in Parkinson's disease.N-acetyl cysteine mitigates the acute effects of cocaine-induced toxicity in astroglia-like cells.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Antioxidants and polyunsaturated fatty acids in multiple sclerosis.Trypanosoma cruzi-Derived Neurotrophic Factor: Role in Neural Repair and Neuroprotection.Oxidative stress and β-amyloid protein in Alzheimer's disease.Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin.Effect of Melatonin on the Expression of Apoptotic Genes in Vitrified-thawed Spermatogonia Stem Cells Type A of 6-Day-Old MiceSafety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial.BAX insertion, oligomerization, and outer membrane permeabilization in brain mitochondria: role of permeability transition and SH-redox regulation.Spinocerebellar degeneration.Granulocyte-colony stimulating factor protects memory impairment in the senescence-accelerated mouse (SAM)-P10.
P2860
Q21003953-ABB03778-8BBE-43D1-B2E4-4D80432CB3DDQ26851676-D17E1CA5-8BA5-4E18-B4F2-4B745FCDA21AQ27936674-5094311D-7B7D-4F9C-9913-5A3F2646E651Q28274093-094BB70E-9F9D-412E-ACE5-5E746CEA6634Q30977301-ED19B3EA-6A4D-45D0-AB13-812133397B53Q33757816-9512018A-BACB-413C-91E6-97B8A813E2B9Q33829221-A186737C-A411-443C-8311-AE520D6A3A44Q34124872-AFC46C00-E3C0-4461-BA50-F45DC8A51545Q34426848-649469E6-F75C-4E5F-B967-40E80E24E5A4Q34481778-2505381A-C97F-436E-94AA-60DA4F9629CDQ34974788-CA8B1BCB-37AF-4F7F-821F-D41BB24CE82FQ35008949-630FF2C8-F3B0-4DC1-8BBD-540B8E9D7405Q35770186-3397577F-0BAE-4A60-AF42-BC267AEF9EB7Q36239170-E427FDCB-09D4-473B-91F9-26D16CCC0A24Q37875699-4B9E3D4A-7861-42DE-8FCB-AD4F2895283AQ37928994-814CD948-FA40-44D2-9770-1937035A2832Q38381854-6321534E-3D0D-48DE-A313-981772DC2CE9Q40449761-976139FA-3069-4989-BD12-0DCC7218BF9FQ41603721-6ACA195E-2379-44C9-BA73-DE6809393696Q42228590-79A315ED-094E-42E4-BBDC-B70EFFBC5047Q42431105-002147AF-735C-447D-BDD6-0D8DCF266419Q44604174-A172278A-6FE2-4027-AFA9-A2129E3C20CEQ51010634-D7DAFD9C-E3F5-4AC9-9DCC-B65CBA4180EE
P2860
Apoptosis modulators in the therapy of neurodegenerative diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Apoptosis modulators in the therapy of neurodegenerative diseases.
@ast
Apoptosis modulators in the therapy of neurodegenerative diseases.
@en
Apoptosis modulators in the therapy of neurodegenerative diseases.
@nl
type
label
Apoptosis modulators in the therapy of neurodegenerative diseases.
@ast
Apoptosis modulators in the therapy of neurodegenerative diseases.
@en
Apoptosis modulators in the therapy of neurodegenerative diseases.
@nl
prefLabel
Apoptosis modulators in the therapy of neurodegenerative diseases.
@ast
Apoptosis modulators in the therapy of neurodegenerative diseases.
@en
Apoptosis modulators in the therapy of neurodegenerative diseases.
@nl
P2093
P2860
P356
P1476
Apoptosis modulators in the therapy of neurodegenerative diseases.
@en
P2093
Deigner HP
Haberkorn U
Kinscherf R
P2860
P304
P356
10.1517/13543784.9.4.747
P407
P577
2000-04-01T00:00:00Z